LR565

Interim study to examine whether adding antidepressant, antipsychotic, and anticonvulsant drugs to the medicaid preferred drug list would be of benefit to Nebraska medicaid or Nebraska medicaid clients

Back to Bill Detail

Print Friendly

LR565 Actions

Date	Action	Journal
Apr 02, 2014	Referred to Health and Human Services Committee	1356
Mar 26, 2014	Referred to Executive Board	1147
Mar 26, 2014	Date of introduction	1147